| Title: |
A phase 2 study of an anti–PD-L1 antibody (atezolizumab) in dedifferentiated chondrosarcoma. |
| Authors: |
Salkeni, Mohamad Adham, Ko, Brian, Van Tine, Brian Andrew, Conley, Anthony Paul, Davis, Elizabeth J., Burgess, Melissa Amber, Close, Julia Lee, Foster, Jared C., O'Sullivan Coyne, Geraldine Helen, Moore, Nancy, Fino, Kristin K., Ferry-Galow, Katherine V., Rosenberger, Christina, Parchment, Ralph E., Sharon, Elad, Doroshow, James H., Chen, Alice P. |
| Source: |
Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p11533-11533, 1p |
| Database: |
Supplemental Index |
